These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30998329)

  • 61. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.
    To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G
    J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Dendroamides, new cyclic hexapeptides from a blue-green alga. Multidrug-resistance reversing activity of dendroamide A.
    Ogino J; Moore RE; Patterson GM; Smith CD
    J Nat Prod; 1996 Jun; 59(6):581-6. PubMed ID: 8786364
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Ailanthone reverses multidrug resistance by inhibiting the P-glycoprotein-mediated efflux in resistant K562/A02 cells.
    Han F; Liu G; Sun C; Wei J
    Cell Mol Biol (Noisy-le-grand); 2018 Dec; 64(15):55-61. PubMed ID: 30672437
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Identification of selenocompounds with promising properties to reverse cancer multidrug resistance.
    Domínguez-Álvarez E; Gajdács M; Spengler G; Palop JA; Marć MA; Kieć-Kononowicz K; Amaral L; Molnár J; Jacob C; Handzlik J; Sanmartín C
    Bioorg Med Chem Lett; 2016 Jun; 26(12):2821-2824. PubMed ID: 27156771
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Sulfocoumarins, specific carbonic anhydrase IX and XII inhibitors, interact with cancer multidrug resistant phenotype through pH regulation and reverse P-glycoprotein mediated resistance.
    Podolski-Renić A; Dinić J; Stanković T; Jovanović M; Ramović A; Pustenko A; Žalubovskis R; Pešić M
    Eur J Pharm Sci; 2019 Oct; 138():105012. PubMed ID: 31330259
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Sipholenol A, a marine-derived sipholane triterpene, potently reverses P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells.
    Shi Z; Jain S; Kim IW; Peng XX; Abraham I; Youssef DT; Fu LW; El Sayed K; Ambudkar SV; Chen ZS
    Cancer Sci; 2007 Sep; 98(9):1373-80. PubMed ID: 17640301
    [TBL] [Abstract][Full Text] [Related]  

  • 67. 5-(3,4,5-trimethoxybenzoyl)-4-methyl-2-(p-tolyl) imidazol (BZML) targets tubulin and DNA to induce anticancer activity and overcome multidrug resistance in colorectal cancer cells.
    Bai Z; Liu X; Guan Q; Ding N; Wei Q; Tong B; Zhao M; Zhang W; Ma L
    Chem Biol Interact; 2020 Jan; 315():108886. PubMed ID: 31682804
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pharmacological strategies for overcoming multidrug resistance.
    Nobili S; Landini I; Giglioni B; Mini E
    Curr Drug Targets; 2006 Jul; 7(7):861-79. PubMed ID: 16842217
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Identification and characterization of the binding sites of P-glycoprotein for multidrug resistance-related drugs and modulators.
    Safa AR
    Curr Med Chem Anticancer Agents; 2004 Jan; 4(1):1-17. PubMed ID: 14754408
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Ethyl lucidenates A reverses P-glycoprotein mediated vincristine resistance in K562/A02 cells.
    Li P; Chen SY; Shen SX; Liu LX; Xu JH; Zhang ZQ
    Nat Prod Res; 2019 Mar; 33(5):732-735. PubMed ID: 29130339
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Sensitization of multidrug-resistant malignant cells by liposomes co-encapsulating doxorubicin and chloroquine through autophagic inhibition.
    Gao M; Xu Y; Qiu L
    J Liposome Res; 2017 Jun; 27(2):151-160. PubMed ID: 27250110
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Tetrandrine Interaction with ABCB1 Reverses Multidrug Resistance in Cancer Cells Through Competition with Anti-Cancer Drugs Followed by Downregulation of ABCB1 Expression.
    Liao D; Zhang W; Gupta P; Lei ZN; Wang JQ; Cai CY; Vera AA; Zhang L; Chen ZS; Yang DH
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31801248
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Reversal of the resistance to STI571 in human chronic myelogenous leukemia K562 cells.
    Mukai M; Che XF; Furukawa T; Sumizawa T; Aoki S; Ren XQ; Haraguchi M; Sugimoto Y; Kobayashi M; Takamatsu H; Akiyama S
    Cancer Sci; 2003 Jun; 94(6):557-63. PubMed ID: 12824882
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Design, synthesis and biological evaluation of chalcones as reversers of P-glycoprotein-mediated multidrug resistance.
    Yin H; Dong J; Cai Y; Shi X; Wang H; Liu G; Tang Y; Liu J; Ma L
    Eur J Med Chem; 2019 Oct; 180():350-366. PubMed ID: 31325783
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Rakicidin D, an inhibitor of tumor cell invasion from marine-derived Streptomyces sp.
    Igarashi Y; Shimasaki R; Miyanaga S; Oku N; Onaka H; Sakurai H; Saiki I; Kitani S; Nihira T; Wimonsiravude W; Panbangred W
    J Antibiot (Tokyo); 2010 Sep; 63(9):563-5. PubMed ID: 20588298
    [No Abstract]   [Full Text] [Related]  

  • 76. Theranostic Nanoprobe Mediated Simultaneous Monitoring and Inhibition of P-Glycoprotein Potentiating Multidrug-Resistant Cancer Therapy.
    Wei Y; Xia H; Zhang F; Wang K; Luo P; Wu Y; Liu S
    Anal Chem; 2019 Sep; 91(17):11200-11208. PubMed ID: 31403276
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo.
    Zhang Z; Ma C; Li P; Wu M; Ye S; Fu L; Xu J
    Cell Commun Signal; 2019 Sep; 17(1):110. PubMed ID: 31472682
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Epimagnolin A, a tetrahydrofurofuranoid lignan from Magnolia fargesii, reverses ABCB1-mediated drug resistance.
    Mitani Y; Satake K; Tsukamoto M; Nakamura I; Kadioglu O; Teruya T; Yonezawa T; Cha BY; Efferth T; Woo JT; Nakagawa H
    Phytomedicine; 2018 Dec; 51():112-119. PubMed ID: 30466608
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Targeted inhibitors of P-glycoprotein increase chemotherapeutic-induced mortality of multidrug resistant tumor cells.
    Nanayakkara AK; Follit CA; Chen G; Williams NS; Vogel PD; Wise JG
    Sci Rep; 2018 Jan; 8(1):967. PubMed ID: 29343829
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Structural and functional aspects of P-glycoprotein and its inhibitors.
    Mollazadeh S; Sahebkar A; Hadizadeh F; Behravan J; Arabzadeh S
    Life Sci; 2018 Dec; 214():118-123. PubMed ID: 30449449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.